Searchable abstracts of presentations at key conferences in endocrinology

ea0020p170 | Thyroid | ECE2009

Primary cavernous hemangioma of the thyroid gland

Michalopoulos Nikolaos , Papadima Artemisia , Lagoudianakis Emmanuel , Panoussopoulos Sotirios-Georgios , Toufektzian Levon , Alevizos Leonidas , Markogiannakis Haridimos , Manouras Andreas

Background: Hemangiomas of the thyroid gland are extremely rare.Case presentation: We report a case of a 78-year-old euthyroid male patient with a primary cavernous hemangioma of the thyroid gland. The patient presented for evaluation of a symptomatic, slowly growing neck mass. He did not have any previous medical history and, moreover, had no history of trauma, FNA or other neck procedures. Ultrasound scan revealed a multinodular goiter and a hypoechoic...

ea0020p229 | Bone/Calcium | ECE2009

Swiss primary hyperparathyroidism cohort study

Trombetti Andrea , Meier Christian , Kraenzlin Marius E , Herrmann Francois R , Henzen Christoph H , Christ Emmanuel R , Brandle Michael , Rizzoli Rene

Objective: The Swiss Primary HyperParaThyroidism (PHPT) Cohort Study is an ongoing, prospective, non-interventional project collecting clinical, densitometric, biochemical and outcome data in patients with PHPT. The aims are to describe the profile of these patients particularly neurobehavioral and cognitive symptoms, changes in calcium and PTH over time and treatment modalities.Methods: Patients newly diagnosed with PHPT and with high serum calcium leve...

ea0010p28 | Diabetes, metabolism and cardiovascular | SFE2005

Ghrelin enhances gastric emptying in diabetic gastroparesis

Murray C , Martin N , Patterson M , Taylor S , Ghatei M , Kamm M , Johnston C , Bloom S , Emmanuel A

Background: Diabetic gastroparesis is a disabling condition with no consistently effective treatment. Ghrelin infusion, in animal studies, increases gastric emptying and reverses post-operative ileus. We present the results of the first double-blind placebo-controlled cross-over study of ghrelin in gastric emptying in patients with diabetic gastroparesis....

ea0010dp7 | Diabetes, metabolism and cardiovascular | SFE2005

Ghrelin enhances gastric emptying in diabetic gastroparesis

Murray C , Martin N , Patterson M , Taylor S , Ghatei M , Kamm M , Johnston C , Bloom S , Emmanuel A

BackgroundDiabetic gastroparesis is a disabling condition with no consistently effective treatment. Ghrelin infusion, in animal studies, increases gastric emptying and reverses post-operative ileus. We present the results of the first double-blind placebo-controlled cross-over study of ghrelin in gastric emptying in patients with diabetic gastroparesis.MethodsTen insulin requiring diabetic patients (5 men, 6 ...

ea0056gp206 | Pituitary Clinical | ECE2018

Clinicopathological correlations in pituitary thyrotroph tumors from a cohort of 23 patients

Capraru Oana-Maria , Vasiljevic Alexandre , Gaillard Celine , Borson-Chazot Francoise , Raverot Veronique , Jouanneau Emmanuel , Trouillas Jacqueline , Raverot Gerald

The thyrotroph tumors or pituitary neuroendocrine tumors (PitNET) classify as tumors of Pit-1 family. These tumors are rare and may be monohormonal, secreting only TSH, or plurihormonal, secreting TSH-GH±PRL, with or without acromegaly. The objectives of this retrospective study were to confirm the frequency of the plurihormonal subtype and to compare the clinical, biological and pathological characteristics of these two pathological subtypes. We retrospectively studied t...

ea0099oc5.4 | Oral Communications 5: Pituitary and Neuroendocrinology | Part I | ECE2024

Mast cells, a new actor in gonadotroph tumors

Ilie Mirela Diana , Lepetit Maxime , Chanal Marie , Vasiljevic Alexandre , Jouanneau Emmanuel , Gandrillon Olivier , Picard Franck , Raverot Gerald , Bertolino Philippe

Background: While gonadotroph tumors are lacking both medical treatment options and prognostic markers, the tumor microenvironment represents a promising tool. The aim of this study was to 1) identify new tumor microenvironment actors in gonadotroph tumors, 2) gain insight into the tumorigenesis mechanisms driven by these tumor microenvironment cells, and 3) identify new tumor microenvironment-related prognostic markers, as well as new therapeutic targets.<p class="abstext...

ea0067o49 | Oral Presentations | EYES2019

Genetic background predicts the presence of oligo- or amenorrhea in girls with anorexia nervosa

Augoulea Areti , Armeni Eleni , Paschou Stavroula A , Deligeoroglou Evangelia , Economou Emmanuel , Papadimitriou Georgios , Stergioti Evgenia , Karountzos Vassilios , Tsitsika Artemis , Panoulis Konstantinos , Lambrinoudaki Irene

Objective: To evaluate the association between genetic background and the presence of oligo- or amenorrhea in a sample of adolescent girls diagnosed with anorexia nervosa compared with controls.Methods: A total of 40 adolescent girls diagnosed with anorexia nervosa aged 14–17 years, as well as 10 age-matched girls, were included in the study. We recorded anthropometric parameters and calculated body mass index (BMI) z-scores adjusted for age, as wel...

ea0063p201 | Diabetes, Obesity and Metabolism 1 | ECE2019

Acquired generalized lipodystrophy: a new cause of Anti-PD-1 immune-related diabetes

Anceau Christine Cugnet , Jehl Alexandre , Vigouroux Corinne , Dalle Stephane , Harou Olivier , Marchand Lucien , Lascols Olivier , Caussy Cyrielle , Thivolet Charles , Laville Martine , Disse Emmanuel

Context: Anti-programmed cell death-1 (Anti-PD-1) antibodies have revolutionized advanced cancer therapy. Anti-PD1 therapy is responsible for immune-related adverse events, with frequent endocrine manifestations. Acquired generalized lipodystrophy (AGL), is a rare disease, thought to be immune-mediated, characterized by loss of adipose tissue and insulin resistance-associated complications. We describe the first case of AGL induced by immune checkpoint therapy.<p class="ab...

ea0063p218 | Diabetes, Obesity and Metabolism 1 | ECE2019

The presence of polymorphic variant A1298C of the MTHFR (methylenetetrahydrofolate reductase) gene is associated with lower body mass index in girls with anorexia nervosa

Paschou Stavroula A , Deligeoroglou Evangelia , Economou Emmanuel , Armeni Eleni , Papadimitriou Georgios , Stergioti Evgenia , Karountzos Vassilios , Tsitsika Artemis K , Augoulea Areti , Panoulis Konstantinos , Lambrinoudaki Irene

Introduction: Single nucleotide polymorphic variants of the methylenetetrahydrofolate reductase (MTHFR) gene have been related with a tendency to gain weight according to recent studies. The aetiology of atypical anorexia nervosa remains under investigation and might be associated with the genetic background. The aim of this study was to evaluate the association between the presence of A1298C or C677T polymorphisms of the MTHFR gene and weight status in a sample of adolescent ...

ea0070aep617 | Pituitary and Neuroendocrinology | ECE2020

SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors

Castellnou Solene , Vasiljevic Alexandre , Lapras Veronique , Raverot Véronique , Alix Eudeline , Borson-Chazot Francoise , Jouanneau Emmanuel , Raverot Gerald , Hélène Lasolle

Context: Somatostatin receptor type 5 (SST5) is inconsistently expressed by corticotroph tumors, with higher expression found in corticotropinomas having ubiquitin-specific protease 8 (USP8) mutations.Aims: To study the correlation between characteristics of corticotropinomasand SST5 expression/USP8 mutation status; to describe the response to pasireotide in 5 patients.Design: Retrospective cohort study.Metho...